Palatin Technologies, Inc. (OTC PINK: PTNT), a biopharmaceutical company advancing innovative treatments targeting the ...

Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, reported preclinical data this week at the Association for Research in ...

If it's your first time using a retinoid, look for retinol creams with ingredients like hyaluronic acid, squalane and ...

Beacon Therapeutics announces phase 2 interim 6 months data from DAWN trial of Laru-zova: London Friday, May 9, 2025, 18:00 Hrs [IST] Beacon Therapeutics Holdings Limited, a leadi ...

Jiarui Nie, a postdoctoral researcher at the National Institutes of Health, is exploring how gold nanoparticles injected into ...

The trial aims to assess the tolerability and safety of the sealant within the first 16 weeks after pars plana vitrectomy.

Imagine a world where lost vision could be restored. A new groundbreaking study might just turn this dream into reality, ...

Lower socioeconomic status was linked with worse eye structure and function at initial presentation in patients undergoing ...

In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined ...

A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and ...

New research reveals that hypoglycemia may worsen diabetic retinopathy by breaking down the blood-retinal barrier.

Retinal detachment is an emergency situation in which the thin tissue layer in the back of your eye lifts away from its usual position. This requires immediate treatment. When part of the tissue ...